Highbridge Capital Management’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-45,600
Closed -$1.32M 1334
2017
Q1
$1.32M Buy
45,600
+32,937
+260% +$1M 0.02% 533
2016
Q4
$416K Buy
+12,663
New +$380K 0.01% 843
2016
Q2
Sell
-9,991
Closed -$363K 1485
2016
Q1
$363K Sell
9,991
-33,167
-77% -$1.17M 0.01% 1105
2015
Q4
$1.73M Buy
+43,158
New +$1.5M 0.03% 569
2014
Q4
Sell
-13,027
Closed -$278K 1233
2014
Q3
$278K Sell
13,027
-24,075
-65% -$551K ﹤0.01% 1025
2014
Q2
$833K Buy
37,102
+8,189
+28% +$191K 0.01% 608
2014
Q1
$731K Sell
28,913
-21,186
-42% -$535K 0.01% 620
2013
Q4
$1.15M Buy
+50,099
New +$1.04M 0.01% 500

Other funds holding EBS